← FDA DRUG APPROVALS

FDA ANDA · ANDA065397

VANCOMYCIN HYDROCHLORIDE

Sponsor: MYLAN LABS LTD

APPLICATION
ANDA065397
TYPE
ANDA
ORIGINAL APPROVAL
2008-12-30
LATEST ACTION
2021-06-04
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

VANCOMYCIN HYDROCHLORIDEPrescription
VANCOMYCIN HYDROCHLORIDE EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
VANCOMYCIN HYDROCHLORIDEPrescription
VANCOMYCIN HYDROCHLORIDE EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2021-06-04Labeling · Supplement 32 · standardAP
2020-08-19Labeling · Supplement 27 · standardAP
2020-08-19Labeling · Supplement 19 · standardAP
2020-08-19Labeling · Supplement 25 · standardAP
2020-08-19Labeling · Supplement 17 · standardAP
2020-08-19Labeling · Supplement 28 · standardAP
2020-08-19Labeling · Supplement 16 · standardAP
2020-08-19Labeling · Supplement 20 · standardAP
2010-11-30Manufacturing (CMC) · Supplement 3AP
2009-06-23Labeling · Supplement 2AP
2009-05-29Labeling · Supplement 1AP
2008-12-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →